Facebook
X
LinkedIn
ForwardExploring the Connection between PCOS and Psychiatric Comorbidities
| Registration |
|---|
Before enrolling in this educational activity, you must log in or create an account. Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage. |
Target Audience
Healthcare professionals.
Description
This on-demand CME webinar explores the relationship between polycystic ovary syndrome (PCOS) and mental health, highlighting an important yet often overlooked aspect of patient care. Participants will review the general pathophysiology of PCOS and examine current evidence linking PCOS to increased rates of psychiatric comorbidities, including anxiety and depression. The activity will emphasize the importance of incorporating routine mental health screenings into clinical care for patients with PCOS and discuss practical intervention strategies and treatment considerations for managing patients with both PCOS and psychiatric conditions. Through this presentation, healthcare professionals will gain greater awareness of the psychological impact of PCOS and strategies to support more comprehensive, patient-centered care.
Please note: Following the recording of this activity, the condition previously referred to as polycystic ovary syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). References to PCOS within the presentation reflect the terminology used at the time of recording.
Educational Need
A practice gap exists in the recognition and management of mental health concerns in patients with polycystic ovary syndrome (PCOS). Emerging evidence demonstrates that individuals with PCOS experience higher rates of mental health conditions, including anxiety and depression; however, the relationship between PCOS and mental health is not consistently discussed or screened for in clinical practice. Despite growing research supporting the impact of PCOS on psychological well-being, awareness among healthcare providers remains limited, and mental health screening is not routinely incorporated into patient encounters. This on-demand webinar will increase provider awareness of the association between PCOS and mental health, highlight current evidence on psychiatric comorbidities, and emphasize the importance of integrating mental health discussions and screening into the care of patients with PCOS to support improved patient outcomes.
Learning Objectives
- Review the general pathophysiology of Polycystic Ovary Syndrome (PCOS).
- Identify which psychiatric morbidities have a higher correlation to PCOS.
- Recognize the importance of routine mental health screenings in patients with PCOS.
- Recall intervention methods when providing care to a patient with PCOS and a psychiatric comorbidity.
Speaker
Erin Clarke
Physician Assistant Student, Des Moines University Medicine and Health Sciences
Faculty Advisors
Nicole Bro, MPAS, PA-C
Associate Professor, Master of Science in Physician Assistant Studies Program, Des Moines University Medicine and Health Sciences
Holland Taylor, DMSc, PA-C, DFAAPA
Department Chair, Master of Science in Physician Assistant Studies Program, Des Moines University Medicine and Health Sciences
Dr. Taylor has reviewed the slides for completeness, clinical accuracy, and recommended action.
Terms of Use and Privacy Policy
Recording date: May 14, 2026
Date of original release: May 14, 2026
Most recent review/update: May 14, 2026
Termination date: May 13, 2029
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University Medicine and Health Sciences (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.50 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This activity is designated for a maximum of 0.50 AMA PRA Category 1 Credit(s)™.
 |  |
Educational Grants
No ineligible company provided financial support for this continuing education activity.
Disclosures
The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Erin Clarke - Speaker
- Nicole Bro, MPAS, PA-C - Faculty Advisor and Content Reviewer
- Holland Taylor, DMSc, PA-C, DFAAPA - Faculty Advisor and Content Reviewer
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 0.50 AMA PRA Category 1 Credits™
- 0.50 AOA Category 2B
- 0.50 CE Contact Hour(s)